Author: Dr. Beth Meneley, DAOM, L.Ac., Wellness Director and Co-Owner, OxygenWell

When red cell mass falls fast, tissues run an oxygen debt. Packed red cells are the first-line fix. Some patients cannot receive them. Religious objection, crossmatch incompatibility, and rare transfusion reactions leave a gap. Hyperbaric oxygen therapy (HBOT) fills that gap by dissolving oxygen directly into plasma so the heart and brain can keep working while hematinics rebuild hemoglobin.

This is a UHMS-accepted indication. It is not a substitute for stopping hemorrhage or for transfusion when transfusion is available and accepted. It is a time-limited bridge.

TLDR

• Exceptional blood loss anemia (severe anemia) is a UHMS-accepted use of HBOT when transfusion is refused or not possible.
• At about 3 ATA of 100% oxygen, dissolved plasma oxygen can approach the 5-6 mL per 100 mL that most tissues extract from blood.
• UHMS notes oxygen delivery becomes problematic near 6 g/dL hemoglobin and clearly inadequate below about 3.6 g/dL.
• Protocols often use 2.0-3.0 ATA for several hours, sometimes more than once a day, then lengthen intervals as hemoglobin recovers with iron, B12, folate, and other hematinics.
• Medicare’s national coverage determination lists exceptional blood loss anemia as a noncovered indication. Commercial PPO coverage varies. OxygenWell can review benefits before you start.
• Sherman Oaks and Calabasas chambers deliver 100% medical-grade oxygen up to 2.4 ATA in grounded monoplace units.

On this page

• What is exceptional blood loss anemia?
• How HBOT carries oxygen without enough hemoglobin
• Who this treatment is for
• What a course of care looks like
• What the evidence actually shows
• Insurance and Medicare
• HBOT for severe anemia in Los Angeles

What is exceptional blood loss anemia?

Clinicians use “exceptional blood loss anemia” and “severe anemia” for the same problem: red cell mass drops so far that hemoglobin cannot meet tissue oxygen demand. Causes include hemorrhage, hemolysis, and aplasia. Speed matters. A slow decline is easier to tolerate than a sudden bleed.

The Undersea and Hyperbaric Medical Society explains the math. Each gram of hemoglobin carries about 1.38 mL of oxygen. Only about 0.003 mL of oxygen dissolves in each milliliter of plasma per mmHg of oxygen tension. Most organ beds extract 5 to 6 mL of oxygen from every 100 mL of blood. At a hemoglobin of 6 g/dL, delivery starts to fail that extraction rate. Below 3.6 g/dL it is clearly inadequate.

StatPearls places the clinical threshold in the same range: delivery is insufficient below 6 g/dL and severely compromised below about 4 g/dL. Symptoms (tachycardia, dyspnea, chest pain, confusion, rising lactate) appear when supply no longer meets demand, often once hemoglobin falls below 7 g/dL.

UHMS also cites work on accumulative oxygen debt after hemorrhage: no survival once debt exceeds 33 L/m², multi-organ failure above 22 L/m², and survival without residual disability at 9 L/m². HBOT’s job is to interrupt that debt while you rebuild red cells.

How HBOT carries oxygen without enough hemoglobin

Henry’s law is simple: more pressure, more gas in solution. Breathing 100% oxygen under pressure drives arterial PO₂ far above the ~100 mmHg of room air. StatPearls notes that at 3 ATA, dissolved plasma oxygen can reach about 6% of blood volume, close to typical tissue extraction. In that window, plasma can carry the oxygen load even when hemoglobin is almost gone.

That is the lesson of Boerema’s 1959 “Life Without Blood” experiments, summarized by both UHMS and StatPearls: piglets exchanged down to 0.4-0.6 g/dL hemoglobin survived short periods at about 3 ATA because dissolved oxygen kept tissues alive.

The effect is temporary. Tissue oxygen stays high for minutes to hours after a dive, then falls. That is why severe cases may need more than one session a day until hematinics lift the baseline.

OxygenWell uses opaque hard-shell monoplace chambers rated to 2.4 ATA with 100% medical-grade oxygen by non-rebreather mask, not a 10-liter concentrator. Certified hyperbaric technicians (most EMT-certified) run each dive, with a PA on site most weekday hours.

Who this treatment is for

HBOT is for patients who already have, or are approaching, symptomatic severe anemia and cannot receive red cells. Common situations:

• Jehovah’s Witnesses and others who decline transfusion on religious grounds. StatPearls notes that U.S. law has long recognized that refusal.
• Patients who cannot be crossmatched, or who have developed antibodies after prior transfusion reactions.
• Massive autoimmune hemolysis, where transfused cells may be destroyed as quickly as they are given.
• Acute surgical, obstetric, or traumatic bleeding while blood is delayed.

It is not first-line care for garden-variety iron deficiency, sickle cell disease (Medicare lists sickle cell anemia among noncovered uses), or chronic anemia that still responds to oral or IV iron. Stop the bleed. Replace volume. Start hematinics. Add HBOT when oxygen debt is already clinical and transfusion is off the table.

Declining blood is not the same as declining care. Bloodless pathways combine smaller phlebotomy, erythropoietin, iron, folate, B12, and, when indicated, HBOT. See our guide to FDA-recognized HBOT indications and Medicare coverage overview.

What a course of care looks like

UHMS describes pulsed HBOT at 2.0-3.0 ATA (0.2-0.3 MPa) with air breaks, sometimes for three to four hours, with surface intervals titrated to symptoms of returning oxygen debt. End-organ warning signs (altered mentation, ischemic ECG changes, ischemic bowel symptoms, hypotension, falling urine output) can guide timing, though they are late signals. As hematinics raise hemoglobin, intervals lengthen.

StatPearls reports the same pressure band (2-3 ATA) and notes that patients with heavier symptoms may need two or three treatments a day. Volume status and nutrition (iron, folate, B vitamins) are not optional add-ons. They are how you exit the chamber schedule.

A 2021 BMJ Case Reports account of a Jehovah’s Witness with pernicious and iron-deficiency anemia documents a nadir hemoglobin of 21 g/L (2.1 g/dL). She received five daily HBOT sessions plus iron and B12 and improved. That is one published course, not a universal protocol. Your team sets dose from vitals, lactate, ECG, and mental status, not from a fixed package.

Pressures above 3 ATA raise oxygen-toxicity risk. Air breaks and hours between dives keep seizures and pulmonary toxicity uncommon. People with diabetes need glucose checks. Claustrophobia is manageable in a well-run monoplace program.

What the evidence actually shows

There is no large randomized trial of HBOT versus no HBOT in untransfusible humans. Ethics make that trial nearly impossible. UHMS grades the animal literature as consistently better short- and long-term survival versus normobaric air or oxygen in both fixed-pressure and fixed-volume hemorrhage models. Human support is case series and case reports. UHMS still concludes that AHA, NCI-PDQ, and BMJ-style evidence reviews support HBOT as a treatment option.

Published examples include emergency-department use in a Jehovah’s Witness with severe blood-loss anemia (Graffeo and Dishong, American Journal of Emergency Medicine, 2013) and obstetric hemorrhage managed with HBOT plus a hemoglobin-based carrier (Thenuwara et al., International Journal of Obstetric Anesthesia, 2017).

HBOT does not replace surgical control of bleeding. It buys time.

Insurance and Medicare

UHMS states CMS historically approved this use. The current Medicare NCD 20.29 lists “Exceptional blood loss anemia” under noncovered conditions. That is the national Medicare rule as published. Commercial PPO policies often still list severe anemia when transfusion is impossible or delayed (for example, some Anthem medical policies). Do not assume either way. We verify benefits and, when needed, discuss cash-pay bridging.

OxygenWell also accepts many FDA-aligned, insurance-supported indications (delayed radiation injury, diabetic Wagner 3+ ulcers, refractory osteomyelitis, compromised grafts and flaps). Start with covered conditions or contact the clinic.

HBOT for severe anemia in Los Angeles

If you or a referred patient cannot receive blood and already shows oxygen-debt physiology, call early. Transfer delay is the usual failure mode. We treat at Sherman Oaks and Calabasas, seven days a week, including evenings, so working families and hospital discharges can start the same day when medically appropriate.

Bring recent CBC, type and screen notes, a medication list, and any religious or antibody documentation your team already has. We coordinate with hematology, surgery, and obstetrics. Sessions are run by CHTs. We do not use “physician-owned” or “physician-supervised” language in our marketing; individual dives are technician-run with a PA present most weekday hours.

Phone: (818) 661-0939. Web: www.oxygenwell.com.

References

• UHMS. 07. Severe Anemia.
• Van Meter K et al. Hyperbaric Therapy in Blood Loss Anemia. StatPearls.
• CMS. NCD 20.29 Hyperbaric Oxygen Therapy.
• Johnson-Arbor K, Verstraete R. Use of hyperbaric oxygenation as an adjunctive treatment for severe pernicious anaemia. BMJ Case Rep. 2021.
• Graffeo C, Dishong W. Severe blood loss anemia in a Jehovah’s Witness treated with adjunctive hyperbaric oxygen therapy. Am J Emerg Med. 2013.
• Thenuwara K et al. HBOT and PEGylated carboxyhemoglobin bovine after postpartum hemorrhage. Int J Obstet Anesth. 2017.